Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Change in Acquisitions & Divestments: 2017-2024

Historic Change in Acquisitions & Divestments for CorMedix (CRMD) over the last 8 years, with Dec 2024 value amounting to $48.1 million.

  • CorMedix's Change in Acquisitions & Divestments rose 322.41% to $33.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.7 million, marking a year-over-year increase of 5.25%. This contributed to the annual value of $48.1 million for FY2024, which is 20.27% down from last year.
  • CorMedix's Change in Acquisitions & Divestments amounted to $48.1 million in FY2024, which was down 20.27% from $60.4 million recorded in FY2023.
  • CorMedix's 5-year Change in Acquisitions & Divestments high stood at $60.4 million for FY2023, and its period low was $7.6 million during FY2021.
  • In the last 3 years, CorMedix's Change in Acquisitions & Divestments had a median value of $48.1 million in 2024 and averaged $45.4 million.
  • In the last 5 years, CorMedix's Change in Acquisitions & Divestments spiked by 658.01% in 2020 and then slumped by 52.89% in 2021.
  • CorMedix's Change in Acquisitions & Divestments (Yearly) stood at $16.1 million in 2020, then crashed by 52.89% to $7.6 million in 2021, then soared by 264.78% to $27.6 million in 2022, then soared by 118.26% to $60.4 million in 2023, then dropped by 20.27% to $48.1 million in 2024.